Research Article

Clinical Outcomes of Critically Ill Patients Using Inhaled Nitric Oxide (iNO) during Intrahospital Transport

Table 1

The demographics, underlying conditions, admission diagnoses, laboratory data, and therapeutic management during the ICU stay.

Group 1 (n = 156)Group 2 (n = 65) value

Age, years (mean ± SDb)50.92 ± 19.82650 ± 18.8220.751
Weight, kg (mean ± SD)80.76390.5230.655
Male gender, no. (%)112/156 (72.4%)47/65 (72.3%)0.985
Admission diagnosis, no. (%)
Sepsis47/156 (30.1%)28/65 (43.1%)0.174
Multiple traumas67/156 (43.6%)24/65 (36.9%)0.179
Other41/156 (26.3%)13/65 (20%)0.97
ICU scores at admission (units, mean ± SD)
APACHEc score26.49 ± 4.725.8 ± 4.280.34
TISSd score29.81 ± 9.5127.57 ± 5.540.07
Laboratory data during iNO treatment in ICU
WBCe (1000 cells/μL, mean ± SD)16.582 ± 9.52314.986 ± 8.6520.245
Hemoglobin (g\dL)11.528 ± 3.03311.420 ± 2.5860.801
Serum urea (mmol/L)58.32 ± 53.08654.29 ± 43.5920.590
Serum creatinine (mmol/L)1.626 ± 2.8921.286 ± 0.9030.354
Blood glucose level (mg/dL)156.79 ± 62.036161.85 ± 61.7390.581
Underlying conditions, no. (%)
CIHDf36/156 (23.1%)13/65 (20.1%)0.83
COPDg24/156 (15.4%)20/65 (30.8%)0.02
HTNh31/156 (19.9%)18/65 (27.7%)0.04
Otheri64/156 (41.7%)14/65 (21.5%)0.03
Therapeutic management and diagnostic tests during ICU stay, no. (%)
Vasopressor support119/156 (76.3%)46/65 (69.2%)0.275
Steroid treatment87/156 (56.4%)40/65 (61.5%)0.482
ECHO study findings
Left ventricle dysfunction (moderate/severe)47/156 (30.1%)20/65 (29.7%)0.297
Right ventricle dysfunction50/156 (32%)18/65 (28%)0.616
Pulmonary hypertension (moderate/severe)62/156 (40.3%)21/65 (33.3%)0.757

Group 1: critically ill patients who were not transported outside of the ICU during their hospitalization period. Group 2: critically ill patients who were transported outside of the ICU during iNO treatment during their hospitalization period. Data are considered statistically significant if . Other diagnoses include intracerebral hemorrhage, cardiogenic shock, eclampsia, SAH, NSTEMI, and pulmonary edema. Vasopressor support: norepinephrine continuous infusion; steroid treatment: concomitant hydrocortisone administration. aICU: intensive care unit. bSD: standard deviation. cAPACHE: Acute Physiology and Chronic Health Evaluation on admission to ICU.. dTISS: Therapeutic Intervention Scoring System on admission to ICU. eWBC: white blood cells. fCIHD: chronic ischemic heart disease. gCOPD: chronic obstructive pulmonary disease. hHTN: chronic hypertension. IOther: diabetes mellitus II, dyslipidemia, alcohol abuse, fat embolism, and pulmonary embolism.